73 related articles for article (PubMed ID: 10049505)
1. The significance of amino acid residue Asp446 for enzymatic stability of rat UDP-glucuronosyltransferase UGT1A6.
Iwano H; Yokota H; Ohgiya S; Yuasa A
Arch Biochem Biophys; 1999 Mar; 363(1):116-20. PubMed ID: 10049505
[TBL] [Abstract][Full Text] [Related]
2. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A
Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114
[TBL] [Abstract][Full Text] [Related]
3. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6.
Senay C; Ouzzine M; Battaglia E; Pless D; Cano V; Burchell B; Radominska A; Magdalou J; Fournel-Gigleux S
Mol Pharmacol; 1997 Mar; 51(3):406-13. PubMed ID: 9058595
[TBL] [Abstract][Full Text] [Related]
4. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
[TBL] [Abstract][Full Text] [Related]
5. Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8.
Fujiwara R; Nakajima M; Yamanaka H; Yokoi T
Drug Metab Dispos; 2009 Jan; 37(1):41-6. PubMed ID: 18832479
[TBL] [Abstract][Full Text] [Related]
6. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
7. A critical amino acid residue, asp446, in UDP-glucuronosyltransferase.
Iwano H; Yokota H; Ohgiya S; Yotumoto N; Yuasa A
Biochem J; 1997 Aug; 325 ( Pt 3)(Pt 3):587-91. PubMed ID: 9271076
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a canine UDP-glucuronosyltransferase.
Soars MG; Smith DJ; Riley RJ; Burchell B
Arch Biochem Biophys; 2001 Jul; 391(2):218-24. PubMed ID: 11437353
[TBL] [Abstract][Full Text] [Related]
9. Interaction of periodate-oxidized UDP-glucuronic acid with recombinant human liver UDP-glucuronosyltransferase 1A6.
Battaglia E; Terrier N; Mizeracka M; Senay C; Magdalou J; Fournel-Gigleux S; Radominska-Pandya A
Drug Metab Dispos; 1998 Aug; 26(8):812-7. PubMed ID: 9698297
[TBL] [Abstract][Full Text] [Related]
10. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
[TBL] [Abstract][Full Text] [Related]
11. The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.
Patana AS; Kurkela M; Goldman A; Finel M
Mol Pharmacol; 2007 Sep; 72(3):604-11. PubMed ID: 17578897
[TBL] [Abstract][Full Text] [Related]
12. Catalytic key amino acids and UDP-sugar donor specificity of a plant glucuronosyltransferase, UGT94B1: molecular modeling substantiated by site-specific mutagenesis and biochemical analyses.
Osmani SA; Bak S; Imberty A; Olsen CE; Møller BL
Plant Physiol; 2008 Nov; 148(3):1295-308. PubMed ID: 18829982
[TBL] [Abstract][Full Text] [Related]
13. Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
Barre L; Fournel-Gigleux S; Finel M; Netter P; Magdalou J; Ouzzine M
FEBS J; 2007 Mar; 274(5):1256-64. PubMed ID: 17263731
[TBL] [Abstract][Full Text] [Related]
14. Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370.
Ouzzine M; Antonio L; Burchell B; Netter P; Fournel-Gigleux S; Magdalou J
Mol Pharmacol; 2000 Dec; 58(6):1609-15. PubMed ID: 11093802
[TBL] [Abstract][Full Text] [Related]
15. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay.
Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R
Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid.
Miles KK; Kessler FK; Smith PC; Ritter JK
Drug Metab Dispos; 2006 Sep; 34(9):1632-9. PubMed ID: 16790558
[TBL] [Abstract][Full Text] [Related]
17. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
18. An alternative promoter contributes to tissue- and inducer-specific expression of the rat UDP-glucuronosyltransferase 1A6 gene.
Auyeung DJ; Kessler FK; Ritter JK
Toxicol Appl Pharmacol; 2001 Jul; 174(1):60-8. PubMed ID: 11437649
[TBL] [Abstract][Full Text] [Related]
19. Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis.
Xiong Y; Bernardi D; Bratton S; Ward MD; Battaglia E; Finel M; Drake RR; Radominska-Pandya A
Biochemistry; 2006 Feb; 45(7):2322-32. PubMed ID: 16475821
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
Narayanan R; LeDuc B; Williams DA
Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
